Publications by authors named "Aaron Lottes"

Claim this Profile
I
Innovation of a Neonatal Peritoneal Dialysis Catheter to Expand Dialysis Capabilities for Critically Ill Neonates in Low-Resource Settings.
Sergio Ruiz Vega, Carl Russell Lll, Siting Zhang, Mignon McCulloch, Aaron Lottes

Blood Purif· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct.
Shin Iwamoto, Kenneth Cavanaugh, Misti Malone, Aaron Lottes, Robert Thatcher

Cardiovasc Revasc Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the Regulatory Pathway for Medical Devices-a Conversation with the FDA, Clinicians, Researchers, and Industry Experts.
Aaron E Lottes, Kenneth J Cavanaugh, Yvonne Yu-Feng Chan, Vincent J Devlin, Craig J Goergen

J Cardiovasc Transl Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study.
Wei Ye, Tanja Böhme, Weiguo Fu, Changwei Liu, Xiaoming Zhang, Aaron E Lottes

Front Cardiovasc Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular Quality Initiative Surveillance of Femoropopliteal Artery Paclitaxel Devices.
Daniel J Bertges, Jens Eldrup-Jorgensen, Susan Robbins, Henry Ssemaganda, Misti Malone, Aaron E Lottes

JACC Cardiovasc Interv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Advancing medical technology innovation and clinical translation via a model of industry-enabled technical and educational support: Indiana Clinical and Translational Sciences Institute's Medical Technology Advance Program - ERRATUM.
Andrew O Brightman, R Lane Coffee, Kara Garcia, Aaron E Lottes, Thomas G Sors

J Clin Transl Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
Daniel J Bertges, Roseann White, Yu-Ching Cheng, Tianyi Sun, Niveditta Ramkumar, Aaron E Lottes

J Vasc Surg· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study.
Masayuki Sugimoto, Kimihiro Komori, Hiroyoshi Yokoi, Takao Ohki, Kimihiko Kichikawa, Aaron E Lottes

J Endovasc Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent.
Michael D Dake, Fabrizio Fanelli, Aaron E Lottes, Erin E O'Leary, Heidi Reichert

Cardiovasc Intervent Radiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program.
Aaron E Lottes, Eleni M Whatley, Sara M Royce, Daniel J Bertges, Carla A Erickson

Am Heart J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing medical technology innovation and clinical translation via a model of industry-enabled technical and educational support: Indiana Clinical and Translational Sciences Institute's Medical Technology Advance Program.
Andrew O Brightman, R Lane Coffee, Kara Garcia, Aaron E Lottes, Thomas G Sors

J Clin Transl Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.
Michael D Dake, Gary M Ansel, Marc Bosiers, Andrew Holden, Osamu Iida, Aaron E Lottes

Cardiovasc Intervent Radiol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS.
Michael D Dake, Gary M Ansel, Aaron E Lottes

CVIR Endovasc· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results.
Kimihiko Kichikawa, Shigeo Ichihashi, Hiroyoshi Yokoi, Takao Ohki, Masato Nakamura, Aaron E Lottes

Cardiovasc Intervent Radiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.
Yvonne Bausback, Tim Wittig, Andrej Schmidt, Thomas Zeller, Marc Bosiers, Aaron E Lottes

J Am Coll Cardiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels-Results from the Zilver PTX Japan Post-Market Surveillance Study.
Stefano Cipollari, Hiroyoshi Yokoi, Takao Ohki, Kimihiko Kichikawa, Masato Nakamura, Aaron E Lottes

J Vasc Interv Radiol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan.
Yukihisa Ogawa, Hiroyoshi Yokoi, Takao Ohki, Kimihiko Kichikawa, Masato Nakamura, Aaron E Lottes

Cardiovasc Intervent Radiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease.
Gary M Ansel, Michael R Jaff, Jeffrey J Popma, Anthony J Battisti, Aaron E Lottes

J Endovasc Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 12-Month Results.
Hiroyoshi Yokoi, Takao Ohki, Kimihiko Kichikawa, Masato Nakamura, Kimihiro Komori, Aaron E Lottes

JACC Cardiovasc Interv· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.
Michael D Dake, Dierk Scheinert, Gunnar Tepe, Jörg Tessarek, Fabrizio Fanelli, Aaron E Lottes

J Endovasc Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained abdominal compression during CPR raises coronary perfusion pressures as much as vasopressor drugs.
Aaron E Lottes, Ann E Rundell, Leslie A Geddes, Andre E Kemeny, Michael P Otlewski

Resuscitation· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new cardiopulmonary resuscitation method using only rhythmic abdominal compression: a preliminary report.
Leslie A Geddes, Ann Rundell, Aaron Lottes, Andre Kemeny, Michael Otlewski

Am J Emerg Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural biochemical changes during ventricular fibrillation with cardiopulmonary resuscitation and the onset of postdefibrillation pulseless electrical activity.
Leslie A Geddes, Rebecca A Roeder, Ann E Rundell, Michael P Otlewski, Andre E Kemeny, Aaron E Lottes

Am J Emerg Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis